Table 4.
Table 4a. IgG3 Antibody levels across age groups in an area of stable malaria transmission
| |||||
---|---|---|---|---|---|
Antigen | Median level (AU) (min, max) for age groups:
|
P value a (trend for age) | |||
2–5 yr (n=14) | 6–15 yr (n=30) | 16–40 yr (n=44) | >40 yr (n=28) | ||
CSP | 2.74 (0.53,56.98) | 5.19 (0.62,81.76) | 15.07 (1.79,231.85) | 23.6 (3.56,223.93) | <0.001 |
LSA-1 | 10.51 (0.41,125.84) | 26.06 (0.31,192.88) | 49.27 (0.15,179.06) | 35.87 (2.60,152.15) | 0.075 |
TRAP | 7.29 (0.79,61.96) | 13.18 (0.85,103.07) | 53.32 (4.73,280.59) | 66.22 (12.71,241.89) | <0.001 |
AMA-1 | 1.86 (0.05,37.37) | 2.55 (0.08,19.99) | 3.66 (0.88,39.53) | 4.38 (1.04,12.61) | 0.002 |
EBA-175 | 4.02 (0.00,116.98) | 8.27 (0.00,113.69) | 5.35 (0.00,171.31) | 3.61 (0.00,34.94) | 0.117 |
MSP-1 | 4.67 (1.19,27.19) | 5.05 (0.59,33.77) | 14.86 (1.13,93.56) | 14.39 (2.11,80.54) | <0.001 |
Table 4b. IgG3 Antibody levels across age groups in an area of unstable malaria transmission
| |||||
---|---|---|---|---|---|
Antigen | Median level (AU) (min, max) for age groupsb:
|
P value a (trend for age) | |||
2–5 yr (n=19) | 6–15 yr (n=12) | 16–40 yr (n=37) | >40 yr (n=28) | ||
CSP | 1.29 (0.21,8.80)* | 1.07 (0.29,2.29)* | 0.58 (0.13,8.17)* | 1.13 (0.15,5.30)* | 0.214 |
LSA-1 | 0.59 (0.19,15.52)* | 0.45 (0.00,0.72)* | 0.99 (0.00,179.06)* | 1.87 (0.03,185.69)* | <0.001 |
TRAP | 0.66 (0.00,54.17)* | 0.59 (0.15,3.39)* | 0.78 (0.05,88.84)* | 2.10 (0.34,125.62)* | 0.006 |
AMA-1 | 0.10 (0.00,0.26)* | 0.09 (0.00,0.25)* | 0.82 (0.07,10.47)* | 0.70 (0.27,6.86)* | <0.001 |
EBA-175 | 0.06 (0.00,2.73)* | 0.05 (0.00,0.95)* | 1.35 (0.00,76.39)* | 2.50 (0.32,79.91) | <0.001 |
MSP-1 | 1.15 (0.36,2.30)* | 1.30 (0.56,1.99)* | 1.36 (0.24,29.71)* | 1.35 (0.62,56.32)* | 0.132 |
Non-parametric test for trend across ordered groups (see Materials and Methods)
Asterisk (*) indicates significantly different from antibody level for same antigen and age group in stable transmission area (P<0.05 by Wilcoxon rank-sum test).